Dr. Rakesh Gaur, FACP, MD, MPH

Dr. Gaur practices at AdventHealth Shawnee Mission in Shawnee Mission, Kansas, part of AdventHealth.

Dr. Gaur's NPI, 1780630368, was assigned on May 26, 2006. Dr. Gaur holds Kansas license 31621.

Dr. Gaur's primary practice is AdventHealth Shawnee Mission, at 9100 W 74th Street, Shawnee Mission, KS 66204 in Johnson County. The practice phone is (913) 676-2152.

Dr. Gaur's primary practice is AdventHealth Shawnee Mission in Shawnee Mission, Kansas, part of AdventHealth. Dr. Gaur is also affiliated with AdventHealth South Overland Park. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Gaur to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gaur practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Gaur's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Gaur's licenses on file in 2 states: Kansas and Missouri.

CMS data shows 2,157 Medicare services from Dr. Gaur across 13 procedure codes in 2024, for 381 Medicare patients. Medicare paid $134,095 for them.

CMS counts 381 Medicare patients who saw Dr. Gaur in 2024. The largest group is 65 to 74, with 176 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gaur's median patient age at 73, with 54% women.

In 2024, Dr. Gaur wrote 1,518 Medicare Part D claims for 223 patients. 82% of them were for generic drugs. CMS names the drug for 1,193 of them, across 41 drugs with 11 or more claims each, at $1,327,145 in total drug cost. In 2023, CMS named 942 claims across 40 drugs.

Dr. Gaur accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gaur as offering telehealth.

Dmand AI links 19 papers to Dr. Gaur, published from 2011 to 2021. 2015 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Anthracyclines and Pancreatic Neoplasms. Dr. Gaur's most frequent co-authors are Samir Narayan, MD, Harry D. Bear, MD and Howard M. Gross, MD.

Dmand AI links Dr. Gaur to 11 clinical trials, 7 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Breast Carcinoma In Situ, Carcinoma, Non-Small-Cell Lung and Melanoma. National Cancer Institute (NCI) sponsors the most, 7. Open Payments lists research payments to Dr. Gaur that name 1 trial.

CMS Open Payments shows 30 general payments to Dr. Gaur from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Immunocore Limited paid the most, $3,654. It also lists 2 research payments totaling $3,300 in 2016, naming 1 clinical trial.